zintick

Charles River Laboratories International CRL

Charles River Laboratories International, Inc. · NYSE · Services-Commercial Physical & Biological Research

$373.98+4.22%close on Oct. 28, 2026 · volume 1.3M · Yahoo Finance

Price, last 47 sessions

$300.00$350.00Sept. 2026Oct. 2026
Aug. 24, 2026 to Oct. 28, 2026 · high $373.98 · low $272.88 · SEC filing, placed when SEC released it

Our coverage

Nothing published yet.

Insider buying and selling

DateInsiderTradeSharesAvg. priceValue
Oct. 22, 2026James C. Foster
director
Sold
10b5-1 plan
24,042$350.00$8.41 million
Oct. 21, 2026Shannon M. Parisotto
CEVP, Disc & Safety Assessment
Sold
10b5-1 plan
2,156$344.41$742,548
Oct. 5, 2026Shannon M. Parisotto
CEVP, Disc & Safety Assessment
Sold
10b5-1 plan
981$308.44$302,580
Sept. 30, 2026Glenn Coleman
EVP & Chief Financial Officer
Bought10$297.43$2,974
Aug. 25, 2026James C. Foster
director
Sold
10b5-1 plan
33,561$300.00$10.07 million
Aug. 19, 2026Shannon M. Parisotto
CEVP, Disc & Safety Assessment
Sold
10b5-1 plan
2,039$294.12$599,711
Aug. 18, 2026Nancy C. Andrews
director
Sold573$285.24$163,443
Aug. 11, 2026Birgit Girshick
Chief Executive Officer, director
Sold
10b5-1 plan
6,500$279.90$1.82 million
Aug. 11, 2026Shannon M. Parisotto
CEVP, Disc & Safety Assessment
Sold
10b5-1 plan
3,714$279.66$1.04 million
Aug. 10, 2026James C. Foster
director
Sold
10b5-1 plan
28,733$275.00$7.90 million
Aug. 6, 2026Michael Gunnar Knell
SVP, Finance and CAO
Sold6,645$260.38
$258.53-$265.17
$1.73 million
Aug. 6, 2026Victoria L. Creamer
EVP & Chief People Officer
Sold4,179$259.16$1.08 million

Latest 12 of 13. Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.

Recent SEC filings

All 21 →